Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.
G. Cornaglia, A. Lönnroth, M. Struelens 
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Salvage therapy for multidrug-resistant tuberculosis
Multidrug-resistant tuberculosis and migration to Europe
Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Herpes zoster in non-hospitalized children
The relationship between tumour necrosis factor-α gene polymorphism and susceptibility and clearance of the persistent hepatitis B virus infection in.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
Genital Chlamydia trachomatis infections
Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals 
Non-antibiotic strategies for sepsis
C.G. Giske, C. Borén, B. Wretlind, G. Kronvall 
H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi 
Tracking changes in the vraSR and graSR two component regulatory systems during the development and loss of vancomycin non-susceptibility in a clinical.
Vector control: a cornerstone in the malaria elimination campaign
Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence,
G. Höffken  Clinical Microbiology and Infection 
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
Laboratory diagnosis and biosafety issues of biological warfare agents
Salvage therapy for multidrug-resistant tuberculosis
L. Zhang, Q. Meng, S. Chen, M. Zhang, B. Chen, B. Wu, G. Yan, X
Elements of design: the knowledge on which we build
Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France  M. Thouverez,
Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
M. Aires-de-Sousa  Clinical Microbiology and Infection 
Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals  E.E. Udo, N. Al-Sweih, B.
A. Bryskier  Clinical Microbiology and Infection 
The practice of travel medicine in Europe
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Update on antifungal resistance in Aspergillus and Candida
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Abstracts cont. Clinical Microbiology and Infection
Antimicrobial drug development – the past, the present, and the future
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis  C.C. Naidoo, M. Pillay  Clinical.
V. Vlahović-Palčevski, U. Dumpis, P. Mitt, J. Gulbinovič, J. Struwe, G
C. Gagliotti, L. Nobilio, M.L. Moro 
An after-hours clinical liaison blood culture service—is it worth it?
Clinical Microbiology and Infection
Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria  E. Presterl, F. Daxböck, W. Graninger,
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
D.L. Monnet, T.L. Sørensen  Clinical Microbiology and Infection 
B.A. Cunha  Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Acquisition of second-line drug resistance and extensive drug resistance during recent transmission of Mycobacterium tuberculosis in rural China  Y. Hu,
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance  A.-P. Magiorakos, A. Srinivasan, R.B. Carey, Y. Carmeli, M.E. Falagas, C.G. Giske, S. Harbarth, J.F. Hindler, G. Kahlmeter, B. Olsson- Liljequist, D.L. Paterson, L.B. Rice, J. Stelling, M.J. Struelens, A. Vatopoulos, J.T. Weber, D.L. Monnet  Clinical Microbiology and Infection  Volume 18, Issue 3, Pages 268-281 (March 2012) DOI: 10.1111/j.1469-0691.2011.03570.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Diagram showing the relationship of MDR, XDR and PDR to each other. Clinical Microbiology and Infection 2012 18, 268-281DOI: (10.1111/j.1469-0691.2011.03570.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Examples of 22 possible antimicrobial susceptibility patterns that can fall under the proposed definitions for MDR, XDR and PDR. □, the isolate is susceptible to all agents listed in category; , the isolate is non-susceptible to some, but not all agents listed in category; ▪, the isolate is non-susceptible to all agents listed in category; , the isolate was not tested for susceptibility to any agent listed in this category. Clinical Microbiology and Infection 2012 18, 268-281DOI: (10.1111/j.1469-0691.2011.03570.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions